1. Alwakid G, Gouda W, Humayun M, et al. Mela-noma Detection Using Deep Learning-Based Classifications. Healthcare (Basel) 2022; 10(12): 2481. [
DOI]
2. Cancer factsheets, Global cancer observatory: 2024. [
Article]
3. Roshandel Gh, Ghanbari A, Salavati F, et al. Annual report of Iranian national population-based cancer registry (2018) Report. Tehran; 2021. [
Article]
4. Quinn AG, Perkins W. Non-Melanoma Skin Cancer and Other Epidermal Skin Tumours Rook's Textbook of Dermatology. 2010. Ox-ford Wiley-Blackwell publication: 1-48. [
DOI]
5. American Cancer Society. Cancer facts and figures: 2023. [
Article]
6. Darjani A, Alizadeh N, Gharaei Nejad K, et al. Epidemiology and Trends of Skin Cancers in Guilan Province, Iran During 2010-2014. Jour-nal of Guilan University of Medical Sciences 2021; 29(4): 154-165. [
DOI]
7. Ghoncheh M, Koohi F, Salehiniya H. Epidemi-ology and trend of skin cancer incidence in southern Iran. Dermatology and Cosmetic 2015; 6(2): 85-92. [
Article]
8. Razi S, Rafiemanesh H, Ghoncheh M, et al. Changing Trends of Types of Skin Cancer in Iran. Asian Pac J Cancer Prev 2015; 16(12): 4955-4958. [
DOI]
9. Skin Cancer Treatment–Health Professional Version. NIH National Cancer Institute: 2021. [
Article]
10. Noorbala MT, Kafaie P. Analysis of 15 years of skin cancer in central Iran (Yazd). Dermatol Online J 2007; 13(4): 1. [
Article]
11. Verkouteren JAC, Ramdas KHR, Wakkee M, et al. Epidemiology of basal cell carcinoma: scholarly review. Br J Dermatol 2017; 177(2): 359-372. [
DOI]
12. Chapalain M, Baroudjian B, Dupont A, et al. Stage IV cutaneous squamous cell carcinoma: treatment outcomes in a series of 42 patients. J Eur Acad Dermatol Venereol 2020; 34(6): 1202-1209. [
DOI]
13. Ciążyńska M, Sławińska M, Kamińska-Winciorek G, et al. Clinical and epidemiological analysis of basosquamous carcinoma: results of the multicenter study. Sci Rep 2020; 10(1): 18475. [
DOI]
14. Olsen CM, Pandeya N, Miranda-Filho A, et al. Does Sex Matter? Temporal Analyses of Mela-noma Trends among Men and Women Sug-gest Etiologic Heterogeneity. J Invest Derma-tol 2025; 145(1): 135-143. [
DOI]
15. Noorbala MT, Mohammadi S, Noorbala M. Cu-taneous malignant melanoma in central iran: a 20-year study. Iran Red Crescent Med J 2013; 15(8): 690-694. [
DOI]
16. Esmaili A, Dehghani Zahedani M, Nili F. P63 marker Expression in Usual Skin Cancers Compared With Non Tumoral Skin Lesions. Iran South Med J 2017; 20(3): 278-286. [
Article]
17. Leiter U, Eigentler T, Garbe C. Epidemiology of skin cancer. In: Sunlight, Vitamin D and Skin Cancer. New York: Springer, 2014, 120-140. [
DOI]
18. Mirzaei M, Razi S, Ghoncheh M, et al. Skin cancer incidence rate and trend in 2004-2008 in Tehran province. jdc 2015; 5(4): 193-199. [
Article]
19. Yazdanfar A, Ghasemi E. Frequency of skin cancers in Hamedan from 1991 to 2007. jdc 2011; 2(2): 115-123. [
DOI]
20. Ahangarzadeh M, Pakhni R, Saidiyar Z, et al. Epidemiology of skin cancer in Iran. The sec-ond annual national congress of Tabari stu-dents and the twenty-second annual congress of the student research committee of Ma-zandaran University of Medical Sciences 2018. [
Article]
21. Nabizadeh R, Salehi Shahidi S, Younesian M, et al. Evaluation of the relationship between global ultraviolet index in different regions of iran and skin cancer in 1383. Iran J Health & Environ 2010; 2(4): 258-267. [
Article]
22. Razi S, Enayatrad M, Mohammadian-Hafshejani A, et al. The Epidemiology of Skin Cancer and its Trend in Iran. Int J Prev Med. 2015; 6: 64. [
DOI]
23. Afzali M, Mirzaei M, Saadati H, et al. Epidemi-ology of skin cancer and changes in its trends in Iran. Feyz Med Sci J 2013; 17(5): 501-511. [
Article]
24. Stanienda-Sokół K, Salwowska N, Sławińska M, et al. Primary Locations of Malignant Mela-noma Lesions Depending on Patients’ Gender and Age. Asian Pac J Cancer Prev 2017; 18(11): 3081-3086. [
DOI]
25. Amouzgar M, Yazdan Panah M, Ebrahimi Rad M. Frequency of different skin cancers in Ghaem Hospital, Mashhad, from 1975 to 1995: A cross-sectional study. Iranian Journal of Dermatology 2006; 9(1): 28-34. [
Article]